You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 7, August 20, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Preliminary Communication
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Neurology
 •Occupational and Environmental Medicine
 •Public Health, Other
 •Diabetes Mellitus
 •Alert me on articles by topic

Arsenic Exposure and Prevalence of Type 2 Diabetes in US Adults

Ana Navas-Acien, MD, PhD; Ellen K. Silbergeld, PhD; Roberto Pastor-Barriuso, PhD; Eliseo Guallar, MD, DrPH

JAMA. 2008;300(7):814-822.

Context  High chronic exposure to inorganic arsenic in drinking water has been related to diabetes development, but the effect of exposure to low to moderate levels of inorganic arsenic on diabetes risk is unknown. In contrast, arsenobetaine, an organic arsenic compound derived from seafood intake, is considered nontoxic.

Objective  To investigate the association of arsenic exposure, as measured in urine, with the prevalence of type 2 diabetes in a representative sample of US adults.

Design, Setting, and Participants  Cross-sectional study in 788 adults aged 20 years or older who participated in the 2003-2004 National Health and Nutrition Examination Survey (NHANES) and had urine arsenic determinations.

Main Outcome Measure  Prevalence of type 2 diabetes across intake of arsenic.

Results  The median urine levels of total arsenic, dimethylarsinate, and arsenobetaine were 7.1, 3.0, and 0.9 µg/L, respectively. The prevalence of type 2 diabetes was 7.7%. After adjustment for diabetes risk factors and markers of seafood intake, participants with type 2 diabetes had a 26% higher level of total arsenic (95% confidence interval [CI], 2.0%-56.0%) and a nonsignificant 10% higher level of dimethylarsinate (95% CI, –8.0% to 33.0%) than participants without type 2 diabetes, and levels of arsenobetaine were similar to those of participants without type 2 diabetes. After similar adjustment, the odds ratios for type 2 diabetes comparing participants at the 80th vs the 20th percentiles were 3.58 for the level of total arsenic (95% CI, 1.18-10.83), 1.57 for dimethylarsinate (95% CI, 0.89-2.76), and 0.69 for arsenobetaine (95% CI, 0.33-1.48).

Conclusions  After adjustment for biomarkers of seafood intake, total urine arsenic was associated with increased prevalence of type 2 diabetes. This finding supports the hypothesis that low levels of exposure to inorganic arsenic in drinking water, a widespread exposure worldwide, may play a role in diabetes prevalence. Prospective studies in populations exposed to a range of inorganic arsenic levels are needed to establish whether this association is causal.


Author Affiliations: Department of Environmental Health Sciences (Drs Navas-Acien and Silbergeld), and Department of Epidemiology, and Welch Center for Prevention, Epidemiology, and Clinical Research (Drs Navas-Acien and Guallar), Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain, and CIBER en Epidemiología y Salud Pública, Madrid, Spain (Dr Pastor-Barriuso); Department of Cardiovascular Epidemiology and Population Genetics, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain, and Department of Medicine, Johns Hopkins Medical Institutions, Baltimore (Dr Guallar).


RELATED LETTERS

Arsenic Exposure and Diabetes Mellitus in the United States
Chin-Hsiao Tseng
JAMA. 2008;300(23):2728.
EXTRACT | FULL TEXT  

Arsenic Exposure and Diabetes Mellitus in the United States—Reply
Ana Navas-Acien and Eliseo Guallar
JAMA. 2008;300(23):2728-2729.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Environmental Arsenic Exposure and Diabetes
Molly L. Kile and David C. Christiani
JAMA. 2008;300(7):845-846.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Arsenic Exposure and Diabetes Mellitus in the United States
Tseng
JAMA 2008;300:2728-2728.
FULL TEXT  

Measuring Arsenic Exposure, Metabolism, and Biological Effects: The Role of Urine Proteomics
Navas-Acien and Guallar
Toxicol Sci 2008;106:1-4.
FULL TEXT  

Arsenic Exposure and Risk for Type 2 Diabetes
JWatch General 2008;2008:5-5.
FULL TEXT  

All you need to read in the other general journals
BMJ 2008;337:a1423-a1423.
FULL TEXT  

Environmental Arsenic Exposure and Diabetes
Kile and Christiani
JAMA 2008;300:845-846.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.